https://news.harvard.edu/gazette/story/2021/05/res
Post# of 150221
![Avatar](/images/ProfileImages/no_avatar_available.jpg)
Blood work for Covid-19? Didn’t Dr Patterson start this over a year ago on the first 10 patients?
The good thing about our PROPOSED New Long Hauler protocol is what Dr. Kelly said about designing the blood work with the FDA and having 60 cell indicators.
This will show the science everyone seeks and confirm what Leronlimab is capable of. We either show the world what our great potential is or we at bare minimum become a tool for the critical patients we know we can help. Knowing exactly how we help by blood work telling the story is the satisfaction we all seek. Because we know it works but MOA is everything. Knowing the complete Method of Action is what will deliver the science for more than just Covid-19. Having a complete understanding of the MOA will show us what diseases we have the most potential for. Ohm has the list but this will make his list much longer and easier for Ohm to add to his list.
Did someone say the next penicillin? It could pale in comparison to Leronlimabs potential. That’s the dream! Stay long and strong... we are well on our way.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)